Stay updated on Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has removed a detailed citation of a phase 3 randomized controlled trial regarding doxorubicin-loaded nanoparticles for advanced hepatocellular carcinoma, which is a significant loss of core content.
    Difference
    0.4%
    Check dated 2025-05-07T19:09:51.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:47:27.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has removed detailed information about the purpose and eligibility criteria for a phase III study on Doxorubicin Transdrug (DT) for advanced Hepatocellular Carcinoma, while adding a new revision number and a specific EudraCT number.
    Difference
    22%
    Check dated 2025-04-16T01:33:25.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T20:01:11.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T13:45:47.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T15:00:13.000Z thumbnail image

Stay in the know with updates to Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.